Skip to content

Harm-reduction information only — not medical advice. In crisis or experiencing adverse effects, contact a healthcare professional or your local emergency services immediately.

AnabolicPlotter logo AnabolicPlotter
Search (no-JS fallback)

Beginner Testosterone Enanthate (12 weeks)

The canonical first cycle: 500 mg Test E per week (250 mg 2×/week) for 12 weeks. The most-cited textbook beginner cycle.

Concentration over time

Model details: Testosterone Enanthate

How to read this chart

This is a study-based example of how testosterone levels change over time. Try different doses or timing to compare the curves.

The calculation uses the same assumptions for everyone. It can't predict your own blood levels or tell you what dose to take.

Only testosterone from the entered doses is shown. Your body's own production isn't included, so this isn't your total blood level.

Study setup and sources

testosterone: exogenous contribution in serum (ng/dL).

The body's own testosterone is excluded. This is the contribution from entered doses, not the total blood level.

Fixed reference profile: Ten adult men with hypogonadism already receiving IM testosterone enanthate; adult model reanalysis of the 2015 cohort. Testosterone enanthate 200 mg/mL in sesame oil (West-Ward), as studied in the IM reference cohort.; Intramuscular. Fixed reference weight: 90.35 kg.

Changing dose or schedule explores a scenario; it does not personalize the reference profile or establish a studied regimen.

Input dose basis: Nominal testosterone enanthate mg

Source exposure scope: The adult IM source cohort received a 200 mg study injection on existing treatment. Other schedules are simulations under fixed linear parameters, not additional observed regimens.

Adult IM testosterone enanthate: injected-drug model component

vogiatzi-2023-enanthate-im-component · version 1

  • Published adult fixed-effect parameters; no individual random effects or pediatric allometric scaling.
  • Zero initial exogenous amount and no endogenous testosterone contribution. Prior treatment is included only when its dose events are entered.
  • Nominal testosterone enanthate dose enters the model directly; no additional ester-mass or bioavailability multiplier.
Model structure
One compartment with absorption
Apparent clearance (CL/F)
50.569 L/hour
Apparent central volume (Vc/F)
13755.8 L
Absorption rate (ka)
0.0831 /hour
Input mass conversion
1 mg modelled mass per mg entered
  • This mathematical injected-drug component is not a measured fraction of an individual blood sample or a prediction of total testosterone.
  • The small source cohort had prior treatment and variable endogenous testosterone. Clinical effects, endogenous recovery and fertility are not modeled.
  • These IM parameters do not describe subcutaneous autoinjectors, other formulations or pediatric patients.
  • Changing a simulated dose or interval does not establish treatment suitability, a testing date or an expected change in adverse effects.
Model values over time. Rows are sampled dates; columns identify each output and its units.
DateTestosterone Enanthate · Testosterone from entered doses only (ng/dL)
W10 ng/dL
W22848.54 ng/dL
W34476.86 ng/dL
W35349.18 ng/dL
W45685.96 ng/dL
W55687.76 ng/dL
W65208.46 ng/dL
W75521.74 ng/dL
W85797.8 ng/dL
W95977.75 ng/dL
W106042.82 ng/dL
W116164.63 ng/dL
W126159.88 ng/dL

The chart uses a bounded time grid. Long horizons can miss brief peaks between samples; shorten the horizon to inspect more detail. Chart peaks are sampled values.

Protocol summary

Beginner Testosterone Enanthate (12 weeks) · 12 weeks starting Oct 30, 26

  • Testosterone Enanthate — 250.0 mg 2×/week (Mon/Thu), weeks 0–12

Protocol overview

Category
aas cycle
Duration
12 weeks
Compounds
1
Tags
beginner, testosterone, 12-week

Compounds in this protocol

How to read this protocol

The chart shows available model curves over the 12-week example. Rows whose model is unavailable are retained for context but produce no curve. Read each model’s details for what its line represents; a plotted level does not predict treatment effects or establish a suitable dose.

The peak/trough explorer examines one complete model interval. The single-dose decline explorer is a separate one-dose scenario; it does not calculate this protocol's washout or a safe treatment-change date. Read the recovery reference for PCT evidence and its limits.

Educational only. Not medical advice. These examples do not predict individual blood levels.